arrow
C

Carmen Ghilardi

Mario Negri Institute for Pharmacological Research IRCCS
H指数:17
被引数:988

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Stroma gene signature predicts responsiveness to chemotherapy in pancreatic ductal adenocarcinoma patient-derived xenograft models

基质基因签名可预测胰腺导管腺癌患者来源的异种移植模型对化疗的反应性

2025-02-040
OA
Onvansertib treatment overcomes olaparib resistance in high-grade ovarian carcinomas

Onvansertib治疗克服了高级别卵巢癌的olaparib耐药性

2024-07-223
OAAI
PGC1α/β Expression Predicts Therapeutic Response to Oxidative Phosphorylation Inhibition in Ovarian Cancer
2022-02-0717
OAAI
VEGF pathway inhibition potentiates PARP inhibitor efficacy in ovarian cancer independent of BRCA status

VEGF通路抑制增强PARP抑制剂在卵巢癌中的功效,而与BRCA状态无关

2021-11-0638
OAAI
A novel L1CAM isoform with angiogenic activity generated by NOVA2-mediated alternative splicing

通过NOVA2-mediated选择性剪接产生的具有血管生成活性的新型L1CAM亚型

2019-03-0450
OA
Thrombospondin-1 is part of a Slug-independent motility and metastatic program in cutaneous melanoma, in association with VEGFR-1 and FGF-2

Thrombospondin-1是皮肤黑色素瘤中独立于Slug的运动和转移计划的一部分,与VEGFR-1和FGF-2有关。

2014-10-1346
OAAI